Details
Title
Author Correction: Short amylin receptor antagonist peptides improve memory deficits in Alzheimer’s disease mouse model
Author
Soudy Rania 1 ; Kimura Ryoichi 2 ; Patel, Aarti 3 ; Fu, Wen 3 ; Kaur Kamaljit 4 ; Westaway, David 5
; Yang, Jing 6 ; Jhamandas, Jack 3
1 University of Alberta, Department of Medicine (Neurology), Neuroscience and Mental Health Institute, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X); Cairo University, Faculty of Pharmacy, Cairo, Egypt (GRID:grid.7776.1) (ISNI:0000 0004 0639 9286)
2 SanyoOnoda City University, Center for Liberal Arts and Sciences, Yamaguchi, Japan (GRID:grid.469470.8) (ISNI:0000 0004 0617 5071)
3 University of Alberta, Department of Medicine (Neurology), Neuroscience and Mental Health Institute, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X)
4 Chapman University School of Pharmacy, Irvine, USA (GRID:grid.254024.5) (ISNI:0000 0000 9006 1798)
5 University of Alberta, Department of Medicine (Neurology), Neuroscience and Mental Health Institute, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X); University of Alberta, Department of Biochemistry, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X); University of Alberta, Center for Prions and Protein Folding Diseases, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X)
6 University of Alberta, Department of Medicine (Neurology), Neuroscience and Mental Health Institute, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X); University of Alberta, Center for Prions and Protein Folding Diseases, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X)
; Yang, Jing 6 ; Jhamandas, Jack 3 1 University of Alberta, Department of Medicine (Neurology), Neuroscience and Mental Health Institute, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X); Cairo University, Faculty of Pharmacy, Cairo, Egypt (GRID:grid.7776.1) (ISNI:0000 0004 0639 9286)
2 SanyoOnoda City University, Center for Liberal Arts and Sciences, Yamaguchi, Japan (GRID:grid.469470.8) (ISNI:0000 0004 0617 5071)
3 University of Alberta, Department of Medicine (Neurology), Neuroscience and Mental Health Institute, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X)
4 Chapman University School of Pharmacy, Irvine, USA (GRID:grid.254024.5) (ISNI:0000 0000 9006 1798)
5 University of Alberta, Department of Medicine (Neurology), Neuroscience and Mental Health Institute, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X); University of Alberta, Department of Biochemistry, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X); University of Alberta, Center for Prions and Protein Folding Diseases, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X)
6 University of Alberta, Department of Medicine (Neurology), Neuroscience and Mental Health Institute, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X); University of Alberta, Center for Prions and Protein Folding Diseases, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X)
Publication year
2022
Publication date
2022
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2656455158
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.